Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and br… Read more
Tatva Chintan Pharma Chem Limited (TATVA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.019x
Based on the latest financial reports, Tatva Chintan Pharma Chem Limited (TATVA) has a cash flow conversion efficiency ratio of 0.019x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹135.54 Million) by net assets (₹7.27 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tatva Chintan Pharma Chem Limited - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Tatva Chintan Pharma Chem Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tatva Chintan Pharma Chem Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tatva Chintan Pharma Chem Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Everybot Inc.
KQ:270660
|
0.028x |
|
Keding Enterprises Co Ltd
TW:6655
|
0.025x |
|
Unggul Indah Cahaya Tbk
JK:UNIC
|
0.088x |
|
OPTGF
PINK:OPTGF
|
N/A |
|
Envela Corp
NYSE MKT:ELA
|
0.039x |
|
Pelican Acquisition Corporation Ordinary Shares
NASDAQ:PELI
|
-0.004x |
|
Indo Borax & Chemicals Limited
NSE:INDOBORAX
|
0.003x |
|
DMS Co.Ltd
KQ:068790
|
0.056x |
Annual Cash Flow Conversion Efficiency for Tatva Chintan Pharma Chem Limited (2018–2025)
The table below shows the annual cash flow conversion efficiency of Tatva Chintan Pharma Chem Limited from 2018 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹7.39 Billion | ₹246.71 Million | 0.033x | -74.90% |
| 2024-03-31 | ₹7.37 Billion | ₹980.44 Million | 0.133x | +146.47% |
| 2023-03-31 | ₹5.15 Billion | ₹277.83 Million | 0.054x | +25.29% |
| 2022-03-31 | ₹4.73 Billion | ₹203.78 Million | 0.043x | -70.60% |
| 2021-03-31 | ₹1.66 Billion | ₹243.19 Million | 0.147x | -31.87% |
| 2020-03-31 | ₹1.18 Billion | ₹253.12 Million | 0.215x | +133.02% |
| 2019-03-31 | ₹797.00 Million | ₹73.56 Million | 0.092x | -47.56% |
| 2018-03-31 | ₹591.56 Million | ₹104.12 Million | 0.176x | -- |